NEW YORK, April 18, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Landos Biopharma, Inc. (NASDAQ: LABP)'s sale to AbbVie Inc. Under the terms of the proposed transaction, AbbVie would acquire Landos for $20.42 per share in cash upon closing, plus one non-tradable contingent value right per share with a value of up to $11.14 per share, subject to the achievement of a clinical development milestone. If you are a Landos shareholder, click here to learn more about your rights and options.

MILWAUKEE, March 11, 2024 /PRNewswire/ -- Ademi LLP is investigating Starrett (NYSE: SCX) for possible breaches of fiduciary duty and other violations of law in its transaction with MiddleGround.

Click here to learn how to join the https://www.ademilaw.com/case/ls-starrett-company or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

In the transaction, Starrett shareholders will receive only $16.19 per share. The transaction agreement unreasonably limits competing transactions for Starrett by imposing a significant penalty if Starrett accepts a competing bid. Starrett insiders will receive substantial benefits as part of change of control arrangements.

NEW YORK, Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The L.S. Starrett Company ("L.S. Starrett's" or the "Company") (NYSE: SCX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether L.S. Starrett's and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The L.S. Starrett Company ("L.S. Starrett's" or the "Company") (NYSE: SCX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether L.S. Starrett's and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of The L.S. Starrett Company ("L.S. Starrett's" or the "Company") (NYSE: SCX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.

The investigation concerns whether L.S. Starrett's and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.